Search

Search Constraints

You searched for: Subject Cachexia

Search Results

1191. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. Issue 2 (22nd November 2013)

1192. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis. Issue 5 (18th June 2017)

1193. The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer. Issue 4 (27th February 2020)

1195. The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients. Issue 3 (18th March 2022)

1197. The atypical β‐blocker S‐oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model. Issue 1 (8th November 2022)

1198. The Authors reply: "Dual energy X‐ray absorptiometry: gold standard for muscle mass?" by Scafoglieri et al. Issue 4 (14th August 2018)

1199. The authors reply: Comment on "The expression landscape of cachexia‐inducing factors in human cancers" by Freire et al. Issue 6 (30th September 2020)